224 related articles for article (PubMed ID: 32120283)
41. Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.
Corben AD; Abi-Raad R; Popa I; Teo CH; Macklin EA; Koerner FC; Taghian AG; Brachtel EF
Arch Pathol Lab Med; 2013 Aug; 137(8):1074-82. PubMed ID: 23899063
[TBL] [Abstract][Full Text] [Related]
42. Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.
Jackisch C; von Minckwitz G; Eidtmann H; Costa SD; Raab G; Blohmer JU; Schütte M; Gerber B; Merkle E; Gademann G; Lampe D; Hilfrich J; Tulusan AH; Caputo A; Kaufmann M
Clin Breast Cancer; 2002 Oct; 3(4):276-80. PubMed ID: 12425756
[TBL] [Abstract][Full Text] [Related]
43. Angiosarcoma arising in the non-operated, sclerosing breast after primary irradiation, surviving 6 years post-resection: A case report and review of the Japanese literature.
Ito T; Tanaka K; Suzumura K; Okamoto Y; Oda K; Hoshi S; Terasaki M
Int J Surg Case Rep; 2016; 24():26-31. PubMed ID: 27179333
[TBL] [Abstract][Full Text] [Related]
44. Systemic therapy in primary angiosarcoma of the spleen.
Ferreira BP; Rodler ET; Loggers ET; Pollack SM; Jones RL
Rare Tumors; 2012 Oct; 4(4):e55. PubMed ID: 23372919
[TBL] [Abstract][Full Text] [Related]
45. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
46. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.
Bramwell VH; Steward WP; Nooij M; Whelan J; Craft AW; Grimer RJ; Taminau AH; Cannon SR; Malcolm AJ; Hogendoorn PC; Uscinska B; Kirkpatrick AL; Machin D; Van Glabbeke MM
J Clin Oncol; 1999 Oct; 17(10):3260-9. PubMed ID: 10506628
[TBL] [Abstract][Full Text] [Related]
48. Current status of paclitaxel in the treatment of breast cancer.
O'Shaughnessy JA; Cowan KH
Breast Cancer Res Treat; 1995; 33(1):27-37. PubMed ID: 7749130
[TBL] [Abstract][Full Text] [Related]
49. Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx.
Gagnon PJ; Galderisi C; Page BR; Holland JM
Head Neck; 2009 Jun; 31(6):829-32. PubMed ID: 18853452
[TBL] [Abstract][Full Text] [Related]
50. Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.
Frasci G; D'Aiuto G; Comella P; Apicella A; Thomas R; Capasso I; Di Bonito M; Cartenì G; Biglietto M; De Lucia L; Maiorino L; Piccolo S; Bianchi U; D'Aniello R; Lapenta L; Comella G
Breast Cancer Res Treat; 1999 Aug; 56(3):239-52. PubMed ID: 10573115
[TBL] [Abstract][Full Text] [Related]
51. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
[TBL] [Abstract][Full Text] [Related]
52. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
53. Angiosarcoma: state of the art and perspectives.
Penel N; Marréaud S; Robin YM; Hohenberger P
Crit Rev Oncol Hematol; 2011 Nov; 80(2):257-63. PubMed ID: 21055965
[TBL] [Abstract][Full Text] [Related]
54. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
[TBL] [Abstract][Full Text] [Related]
55. Angiosarcoma of the breast: a new therapeutic approach?
Benevento R; Carafa F; Di Nardo D; Pellino G; Letizia A; Taddeo M; Gambardella A; Canonico S; Santoriello A
Int J Surg Case Rep; 2015; 13():30-2. PubMed ID: 26092711
[TBL] [Abstract][Full Text] [Related]
56. Primary and secondary breast angiosarcoma: single center report and a meta-analysis.
Abdou Y; Elkhanany A; Attwood K; Ji W; Takabe K; Opyrchal M
Breast Cancer Res Treat; 2019 Dec; 178(3):523-533. PubMed ID: 31522347
[TBL] [Abstract][Full Text] [Related]
57. Management of Localized Breast Angiosarcoma by North American Radiation and Medical Oncologists.
Hatfield J; McClelland S; Luo J; Degnin C; Chen Y; Maggiore RJ; Mitin T
Clin Breast Cancer; 2018 Dec; 18(6):498-503. PubMed ID: 30482726
[TBL] [Abstract][Full Text] [Related]
58. A new case of radiation-induced breast angiosarcoma.
Verdura V; Di Pace B; Concilio M; Guastafierro A; Fiorillo G; Alfano L; Nicoletti GF; Savastano C; Cascone AM; Rubino C
Int J Surg Case Rep; 2019; 60():152-155. PubMed ID: 31228777
[TBL] [Abstract][Full Text] [Related]
59. Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer.
Diéras V; Fumoleau P; Romieu G; Tubiana-Hulin M; Namer M; Mauriac L; Guastalla JP; Pujade-Lauraine E; Kerbrat P; Maillart P; Pénault-Llorca F; Buyse M; Pouillart P
J Clin Oncol; 2004 Dec; 22(24):4958-65. PubMed ID: 15611510
[TBL] [Abstract][Full Text] [Related]
60. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
Gradishar WJ
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
